Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040332435> ?p ?o ?g. }
- W2040332435 endingPage "2531" @default.
- W2040332435 startingPage "2526" @default.
- W2040332435 abstract "Total inhibin is the sum of precursors, subunits, and mature molecules of inhibin, which the normal ovary nearly stops to produce after menopause, whereas ovarian tumors still release.The aim of the present study was to evaluate whether the serum concentration of total inhibin has the sensitivity/specificity characteristics to become a diagnostic test for epithelial ovarian cancer in postmenopausal women.This was a controlled, cross-sectional study.The study was conducted at the University of Siena.Blood specimens were collected from postmenopausal women with: 1) epithelial ovarian cancer, stage II-III (n = 89); 2) benign ovarian tumors (n = 25); 3) breast (n = 10), colon (n = 10), and stomach (n = 10) cancers; and 4) controls (n = 95). In the group of women with epithelial ovarian cancer, blood specimens were also collected after surgical removal of the tumor. In four cases of women with stage IIC mucinous tumor, blood specimens were collected during the follow-up time.Total inhibin was measured by a new double-antibody ELISA.Women with epithelial ovarian cancers showed serum total inhibin levels significantly higher than those with benign tumor or with nonovarian tumors or controls (P < 0.001). Patients with serous (n = 40) or mucinous tumors (n = 17) showed the highest total inhibin levels (P < 0.001). At 95% specificity, the total inhibin assay detected 37 of 40 (93%) serous tumors and 16 of 17 (94%) mucinous tumors. When total inhibin was combined with CA-125, all cases of serous and mucinous tumors were detected, and the overall sensitivity for epithelial ovarian cancers was 99% at 95% specificity. A significant decrease of total inhibin levels was shown in women with serous and mucinous carcinoma as result of surgery (P < 0.001). In the four women who were followed up, recurrence was associated to an increase of total inhibin levels.The present data show that total inhibin is a sensitive and specific marker of epithelial ovarian cancers in postmenopausal women. Total inhibin may therefore be combined with CA-125 for noninvasive diagnosis of epithelial ovarian cancer and may also be a useful serum marker to monitor disease-free intervals." @default.
- W2040332435 created "2016-06-24" @default.
- W2040332435 creator A5012239685 @default.
- W2040332435 creator A5027662409 @default.
- W2040332435 creator A5030268137 @default.
- W2040332435 creator A5049594185 @default.
- W2040332435 creator A5051961211 @default.
- W2040332435 creator A5067332461 @default.
- W2040332435 creator A5067881201 @default.
- W2040332435 creator A5079842683 @default.
- W2040332435 date "2007-07-01" @default.
- W2040332435 modified "2023-09-26" @default.
- W2040332435 title "Total Inhibin Is a Potential Serum Marker for Epithelial Ovarian Cancer" @default.
- W2040332435 cites W1911310027 @default.
- W2040332435 cites W1954299883 @default.
- W2040332435 cites W1965772308 @default.
- W2040332435 cites W1981268896 @default.
- W2040332435 cites W1987353659 @default.
- W2040332435 cites W2019924193 @default.
- W2040332435 cites W2028387622 @default.
- W2040332435 cites W2029131356 @default.
- W2040332435 cites W2033162087 @default.
- W2040332435 cites W2035066075 @default.
- W2040332435 cites W2036142297 @default.
- W2040332435 cites W2050620572 @default.
- W2040332435 cites W2052465225 @default.
- W2040332435 cites W2064224644 @default.
- W2040332435 cites W2090443860 @default.
- W2040332435 cites W2106089380 @default.
- W2040332435 cites W2110531858 @default.
- W2040332435 cites W2144659676 @default.
- W2040332435 cites W2157764555 @default.
- W2040332435 cites W2167698496 @default.
- W2040332435 doi "https://doi.org/10.1210/jc.2007-0235" @default.
- W2040332435 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17473066" @default.
- W2040332435 hasPublicationYear "2007" @default.
- W2040332435 type Work @default.
- W2040332435 sameAs 2040332435 @default.
- W2040332435 citedByCount "26" @default.
- W2040332435 countsByYear W20403324352012 @default.
- W2040332435 countsByYear W20403324352013 @default.
- W2040332435 countsByYear W20403324352015 @default.
- W2040332435 countsByYear W20403324352020 @default.
- W2040332435 countsByYear W20403324352022 @default.
- W2040332435 crossrefType "journal-article" @default.
- W2040332435 hasAuthorship W2040332435A5012239685 @default.
- W2040332435 hasAuthorship W2040332435A5027662409 @default.
- W2040332435 hasAuthorship W2040332435A5030268137 @default.
- W2040332435 hasAuthorship W2040332435A5049594185 @default.
- W2040332435 hasAuthorship W2040332435A5051961211 @default.
- W2040332435 hasAuthorship W2040332435A5067332461 @default.
- W2040332435 hasAuthorship W2040332435A5067881201 @default.
- W2040332435 hasAuthorship W2040332435A5079842683 @default.
- W2040332435 hasBestOaLocation W20403324351 @default.
- W2040332435 hasConcept C121608353 @default.
- W2040332435 hasConcept C126322002 @default.
- W2040332435 hasConcept C134018914 @default.
- W2040332435 hasConcept C142724271 @default.
- W2040332435 hasConcept C146357865 @default.
- W2040332435 hasConcept C150173356 @default.
- W2040332435 hasConcept C151730666 @default.
- W2040332435 hasConcept C2778324911 @default.
- W2040332435 hasConcept C2778562196 @default.
- W2040332435 hasConcept C2780427987 @default.
- W2040332435 hasConcept C2781447364 @default.
- W2040332435 hasConcept C2992773878 @default.
- W2040332435 hasConcept C530470458 @default.
- W2040332435 hasConcept C71924100 @default.
- W2040332435 hasConcept C86803240 @default.
- W2040332435 hasConcept C90924648 @default.
- W2040332435 hasConceptScore W2040332435C121608353 @default.
- W2040332435 hasConceptScore W2040332435C126322002 @default.
- W2040332435 hasConceptScore W2040332435C134018914 @default.
- W2040332435 hasConceptScore W2040332435C142724271 @default.
- W2040332435 hasConceptScore W2040332435C146357865 @default.
- W2040332435 hasConceptScore W2040332435C150173356 @default.
- W2040332435 hasConceptScore W2040332435C151730666 @default.
- W2040332435 hasConceptScore W2040332435C2778324911 @default.
- W2040332435 hasConceptScore W2040332435C2778562196 @default.
- W2040332435 hasConceptScore W2040332435C2780427987 @default.
- W2040332435 hasConceptScore W2040332435C2781447364 @default.
- W2040332435 hasConceptScore W2040332435C2992773878 @default.
- W2040332435 hasConceptScore W2040332435C530470458 @default.
- W2040332435 hasConceptScore W2040332435C71924100 @default.
- W2040332435 hasConceptScore W2040332435C86803240 @default.
- W2040332435 hasConceptScore W2040332435C90924648 @default.
- W2040332435 hasIssue "7" @default.
- W2040332435 hasLocation W20403324351 @default.
- W2040332435 hasLocation W20403324352 @default.
- W2040332435 hasOpenAccess W2040332435 @default.
- W2040332435 hasPrimaryLocation W20403324351 @default.
- W2040332435 hasRelatedWork W1977704070 @default.
- W2040332435 hasRelatedWork W1978549386 @default.
- W2040332435 hasRelatedWork W1981299372 @default.
- W2040332435 hasRelatedWork W1981477956 @default.
- W2040332435 hasRelatedWork W2033909461 @default.
- W2040332435 hasRelatedWork W2062075687 @default.
- W2040332435 hasRelatedWork W2077416684 @default.